Methods and systems for determining spatial patterns of biological targets in a sample
The present disclosure provides methods and assay systems for use in spatially encoded biological assays, including assays to determine a spatial pattern of abundance, expression, and/or activity of one or more biological targets across multiple sites in a sample. In particular, the biological targets comprise proteins, and the methods and assay systems do not depend on imaging techniques for the spatial information of the targets. The present disclosure provides methods and assay systems capable of high levels of multiplexing where reagents are provided to a biological sample in order to address tag the sites to which reagents are delivered; instrumentation capable of controlled delivery of reagents; and a decoding scheme providing a readout that is digital in nature.
1. A system for detecting a nucleic acid in a cell of a plurality of cells, the system comprising:
a first module for delivering the cell in the plurality of cells through an addressing channel of multiple addressing channels in a microfluidic device, wherein the addressing channel comprises a probe comprising (i) an address tag having a sequence that uniquely identifies the addressing channel; and (ii) a primer region; and
a second module for allowing a portion of the probe to hybridize with the nucleic acid from the cell and extending the probe using the nucleic acid as a template to generate an extended product in the addressing channel.
2. The system of claim 1 , further comprising a third module for pooling the extended product from each of the addressing channels.
3. The system of claim 1 , wherein the second module further comprises an enzyme for lysing the cell in the addressing channel.
4. The system of claim 1 , further comprising a fourth module for amplifying the extended product from each of the addressing channels.
5. The system of claim 1 , further comprising amplifying the extended product, wherein the amplifying is performed by polymerase chain reaction.
6. The system of claim 5 , wherein the polymerase chain reaction occurs outside of the microfluidic device.
7. The system of claim 1 , further comprising a fifth module for determining (i) the sequence of the address tag or a complement thereof, and (ii) all or a portion of the extended product, and using the determined sequences of (i) and (ii) to associate the nucleic acid with the addressing channel, thereby detecting the nucleic acid in the plurality of cells.
8. The system of claim 7 , wherein the determining step comprises sequencing (i) the sequence of the address tag or a complement thereof, and (ii) all or a portion of the extended product.
9. The system of claim 1 , further comprising a sixth module for imaging the cell.
10. The system of claim 9 , wherein the cell is stained using immunohistochemistry or immunofluorescence prior to imaging.
11. The system of claim 9 , wherein the imaging occurs after delivering the plurality of cells through the multiple addressing channels.
12. The system of claim 9 , wherein the imaging occurs before the probe hybridizes with the nucleic acid from the cell.
13. The system of claim 1 , wherein the multiple addressing channels are substantially parallel to each other.
14. The system of claim 1 , wherein the multiple addressing channels is n addressing channels, wherein n is an integer between 5 and 100.
15. The system of claim 14 , wherein n is an integer between 25 and 75.
16. The system of claim 14 , wherein n is about 50.
17. The system of claim 1 , wherein each of the multiple addressing channels has a width of about 5 micrometers to about 500 micrometers.
18. The system of claim 1 , wherein each of the multiple addressing channels has a depth of about 5 micrometers to about 500 micrometers.
19. The system of claim 1 , wherein each of the multiple addressing channels has a distance from other multiple addressing channels in the microfluidic device of about 5 micrometers to about 2 millimeters.
20. The system of claim 1 , wherein the nucleic acid comprises RNA.
21. The system of claim 20 , wherein a portion of the RNA comprises a poly(A) sequence.
22. The system of claim 20 , wherein the RNA is an mRNA.
23. The system of claim 1 , wherein the nucleic acid comprises DNA.
24. The system of claim 23 , wherein the nucleic acid is genomic DNA or mitochondrial DNA.
25. The system of claim 1 , wherein the probe further comprises a variable tag region, a sequencing adaptor, or a combination thereof.
26. The system of claim 1 , wherein the probe comprises a nucleic acid sequence.
27. The system of claim 1 , wherein each addressing channel of the multiple addressing channels receives a cell from the plurality of cells.
28. The system of claim 1 , wherein the plurality of cells is from a tissue sample.
29. The system of claim 28 , wherein the tissue sample is a freshly isolated tissue sample, a fixed tissue sample, or a frozen tissue sample.
30. The system claim 1 , wherein the plurality of cells is from cultured cells.